Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Atrial high-rate episodes (AHRE) are detected by implantable devices.
• The clinical significance and management of AHRE remain unclear.
• AHRE are linked to a higher stroke risk compared to no AHRE.

Purpose of the Study:

• To evaluate the therapeutic implications of AHRE.
• To assess the role of oral anticoagulation in mitigating stroke risk for AHRE patients.
• To determine the efficacy and safety of anticoagulation in AHRE.

Main Methods:

• Continuous rhythm monitoring using pacemakers, defibrillators, or implantable cardiac monitors.
• Observational analysis of stroke risk and bleeding rates in patients with AHRE.
• Comparison of stroke rates between AHRE patients and atrial fibrillation patients.

Main Results:

• AHRE presence is associated with increased stroke risk.
• Oral anticoagulation may reduce stroke risk in AHRE patients.
• The stroke rate in AHRE is lower than in atrial fibrillation, but anticoagulation carries a ~2% annual severe bleeding risk.

Conclusions:

• The efficacy and safety of oral anticoagulation for AHRE require further investigation.
• More research is necessary to establish definitive treatment guidelines for AHRE.
• Understanding the net clinical benefit of anticoagulation in AHRE is crucial.